The Rho GTPase family is involved in actin dynamics and regulates the barrier function of the endothelium. One of the main barrier-promoting Rho GTPases is Cdc42, also known as cell division control protein 42 homolog. Currently, regulation of Cdc42-based signaling networks in endothelial cells (ECs) lack molecular details. To examine these, we focused on a subset of 15 Rho guanine nucleotide exchange factors (GEFs), which are expressed in the endothelium.
Introduction
The Rho family of small GTPases belongs to the superfamily of Ras GTPases. Approximately 20 Rho GTPases have been identified, some of which show >85% homology and functional redundancy 1,2 . Via differential actin cytoskeleton remodeling, Rho GTPases regulate a range of cellular responses, including cell adhesion, -migration and -polarity 3 . In the endothelium, these processes form the basis of vascular homeostasis and dynamic regulation of endothelial barrier function. Consequently, Rho GTPases are key molecular components in EC biology.
Rho GTPases act as molecular switches, and their activation and downstream signaling is regulated by three groups of proteins 4 . While Rho guanine nucleotide exchange factors (GEFs) mediate the Rho GTPase GDP-GTP exchange, leading to an activated GTPase, the intrinsic GTP hydrolysis, i.e. inactivation, is stimulated by Rho GTPase activating proteins (GAPs). Additionally, members of the Rho guanine dissociation inhibitors (GDI) family, sequester inactive Rho GTPases in the cytoplasm, securing a large pool of Rho GTPases available for rapid cellular responses to external cues. Roughly 80 GEFs, 70 GAPs and 3 GDIs have been identified, greatly outnumbering the ~20 Rho GTPases. Consequently, the regulation of Rho GTPase activity, both in time and place, is highly complex 3, 4 .
GEFs comprise the largest group of Rho GTPase regulators, consisting of two families;
11 dedicator of cytokinesis (Dock) -and 74 diffuse B-cell lymphoma (Dbl) proteins [5] [6] [7] [8] [9] [10] [11] [12] [13] . The
Dbl family has been repeatedly linked to Rho activation. Members of this family contain a Dblhomology (DH) domain of around 170-190 residues, that regulates the Rho GTPase GDP-GTP exchange 10, 13 . In addition, the majority of DH-containing Dbl family members encode a pleckstrin homology (PH) domain of approximately 120 residues. PH domains can contribute to GEF autoinhibition, activity regulation, subcellular localization, phospholipid binding and to the scaffolding of related signaling proteins 4, 10, 14 . However, these functions are relatively unexplored and in general PH-domain specific functions are poorly documented.
Although GEF-Rho GTPase interactions are critical determinants in Rho GTPase signaling networks, molecular details are still missing. Additionally, current studies are mostly based on studies with isolated components or pull-down experiments on lysed cells. The in vitro data provide mechanistic details 13 , but lack physiological relevance due to the absence of cellular context. Here, we specifically focused on GEF-Cdc42 interactions in the cellular environment, with special emphasis on the endothelium. We selected a subset of endothelial 
Results

Cdc42 GEF selection in human ECs
Over the past years the Rho GTPase Cdc42 has been identified as a key regulator in endothelial barrier control [15] [16] [17] [18] 22 , and is illustrated in Figure 1 .
GEF-phenotypes in ECs
Most of the selected GEFs have not been previously studied in ECs. The initial characterization of their potential function entailed analysis of their intracellular localization. Unfortunately, due to the lack of proper antibodies, it is not possible to study localization of the endogenous proteins. Therefore, we generated GEF fusions with the cyan fluorescent protein mTurquoise2 (mTq2), to explore individual GEF localization.
Analysis of expression of mTq2-GEFs in confluent EC monolayers was combined with immunofluorescent staining for F-actin and the cell-cell contact protein Vascular Endothelial (VE)-cadherin ( Figure 2A ). This strategy induced notable phenotypes in ECs. A specific 'protruding' phenotype was observed for FGD1, PLEKHG2 and Vav2. In cells expressing these GEFs, the peripheral membrane protrudes beyond the VE-cadherin-positive cell-cell junction, a phenomenon that is also induced by the expression of constitutively active Cdc42 (Cdc42-G14V) ( Figure 2B ). FGD1 and Vav2 furthermore show a marked increase in cortical actin, while PLEKHG2 itself partly localized at F-actin fibers. In contrast to this protruding phenotype, expression of -Pix resulted in a 'contractile' phenotype, marked by an increase in F-actin stress fibers and a jagged appearance of the VE-cadherin complex. Pix, FGD1, FGD5,  ITSN1, ITSN2, PLEKHG1, PLEKHG2, PLEKHG4, [23] [24] [25] . No specific phenotypes were observed for -Pix, Asef2, FGD5 and PLEKHG4
Together, these data localize mTq2-tagged GEFs in human ECs and show that the GEFs induce specific and differential phenotypes, inferred from endogenous F-actin-and VEcadherin labeling.
A single-cell FRET-based approach to study GEF activation of Cdc42
The GEF localization approach revealed various GEF-specific phenotypes in ECs. Although some of these phenotypes hint towards activation of Cdc42, direct evidence is lacking. In order to study GEF-mediated Cdc42 activation directly, we applied a single cell FRET-biosensor imaging strategy, summarized in Figure 3 . This strategy involves a FRET biosensor which records Cdc42 activation 26 . The sensor read-out uses a cyan fluorescent protein (CFP) and a yellow fluorescent protein (YFP) as a FRET pair that allows ratiometric image-based analysis, in which an increase in YFP/CFP ratio corresponds to an increase in Cdc42 activation.
In our experimental setup, the Cdc42 sensor is co-expressed with either a soluble mCherry (as a control) or a mCherry-tagged GEF of interest. The fluorescence intensity of mCherry will reflect the concentration of the GEF. Cells that showed both sensor-as well as mCherry expression within the intensity range of 4-600, were selected. Next, image acquisition and processing resulted in a ratiometric YFP/CFP image, including a corresponding average YFP/CFP value. These average YFP/CFP values of multiple cells were plotted for both the control as well as for the GEF-expressing cells ( Figure 3 ). In turn, YFP/CFP ratios and corresponding mCherry intensities were plotted in mCherry-YFP/CFP ratio graphs (supplementary figure S1 ). The rationale is that the Rho GTPase activity, assessed from the YFP/CFP ratio, is correlated with GEF activity, inferred from mCherry fluorescence. To quantify the relationship between activity and GEF concentration, the data points (each dot represents a single cell) were subjected to linear regression analysis via the Theil-Sen estimator method. The Theil-Sen estimator method calculates the median slope, which we take as a measure of relative activity of a GEF. For a quantitative comparison between conditions, we plot the median activity and the 95% confidence interval (Figure 3 ). Details of this Theil-Sen estimator analyses are summarized in Supplemental Figure S1 .
In summary, the cell-based analysis of Rho GTPase activation with FRET based biosensors and tagged GEFs enables the determination and direct quantitative comparison of GEF activity in single living ECs. 
GEF expression induces specific Cdc42 and Rac1 activation patterns in ECs
The workflow described in the previous section was applied for all selected GEFs listed in Figure 1 . First, the YFP over CFP ratios were determined for ectopically expressed GEFs.
( Figure 4A ). Next to Cdc42 activation also Rac1 activation was monitored, using a validated Rac1 FRET sensor 25 ( Figure 4B ). The YFP/CFP ratios were subsequently converted into 'relative activity' values by taking GEF expression levels into account. The resulting activities are sorted according to their median value and plotted with a 95% confidence interval ( Figure   4C and D). Based on arbitrarily set cut-off values we have defined three levels of activation of Overall, these data show distinct GEF-induced Cdc42 and Rac1 activation profiles in live ECs. Different GEFs can be divided into low-, medium-, and high activators, with differential preference for Cdc42 or Rac1 GTPases.
TIAM1 exclusively activates Rac1, and not Cdc42
As shown in Figure 4 , pRex1, TrioN and Vav2 all, to some extent, activate Cdc42. Previous literature, however, mainly describes these GEFs as Rac1 activators. To test the specificity and discriminative power of our assay, we used the GEF TIAM1 as an additional negative control.
Based on vitro data 13 , TIAM1 is highly selective, showing high GEF activity towards Rac1, but not towards Cdc42. Applying the same strategy as described in Figure 3 , the catalytic domain of TIAM1 was used to study the effect on Cdc42 or Rac1. Ectopic expression of mCherry-TIAM1, combined with the Cdc42 FRET sensor, did not show Cdc42 activation based on the YFP/CFP ratio ( Figure 5A ) and also its relative activity was near the control value ( Figure 5C ). In contrast to Cdc42, strong effects were observed when the Rac1 sensor was used in combination with TIAM1. Both the YFP/CFP ratios as well as the relative activity were strongly increased relative to the control ( Figure 5B&D ). These data suggest that the Cdc42 biosensor is not sensitive for Rac GEFs and that induction of Rac1 activity does not (indirectly) result in Cdc42 activation in endothelial cells.
Collectively, our data demonstrate that the Cdc42 and Rac1 biosensors report with high selectivity on GEF activity in a cellular context. 
Catalytic GEF domains induce differential Cdc42 activation patterns
As can be inferred from the protein domain structures in Figure 1 , the GEFs of interest belong to the Dbl family (containing a DH and PH domain). The activity that we have measured for the FL GEFs ( Figure 4 ) is a basal activity determined by the combined role of all the domains that are present. Previous studies have demonstrated that the DH domain is responsible for the catalytic activity towards their preferred targets 4, 10, 13 . The PH domain that is adjacent to the DH domain in the majority of GEFs has a less clearly defined role. Finally, domains beyond the DHPH tandem can have diverse regulatory roles, including localization, autoinhibition, proteinprotein or protein-lipid interactions. To study the role of the catalytic unit in more detail, we selected a number of GEFs to examine the activity of the DH domain and the role of the PH domain.
In total eight GEFs from all three levels of Cdc42 activation (weak, intermediate, strong)
were selected, including FGD1, FGD5, ITSN1, ITSN2, PLEKHG1, PLEKHG2, PLEKHG4 and pRex1. Corresponding GEF DHPH domain alignments (acquired from ClustalW) highlight the amino acid sequence homology between these proteins ( Figure 6 ). We generated mCherryfused DH, and DHPH constructs. Since it has been shown that recruitment of a GEF to the plasma membrane is sufficient to increase Rho GTPase activity, we also made variants with a plasma membrane targeting signal from Lck. represents conserved residues between groups of strongly similar properties, . represents conserved residues between groups of weakly similar properties. 
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379 EKQKWLDAIIREREQR-------: * : activation. This is well in line with previous studies that characterized FGD1 as a Cdc42 GEF involved in faciogenital dysplasia, a human disease that affects skeletogenesis 27, 28 . We observe most prominent Rac1 activation for TrioN, pRex1, Vav2 and TIAM1, in line with previous studies which defined these as Rac1 GEFs 13 . Mainly for pRex1, and to some extent for TrioN and Vav2, we could also detect elevated Cdc42 activation. Strikingly, the activity of pRex1 towards Cdc42 has been observed using purified components 13 , but not in cellular context 29 .
Whether It is unlikely that the effect on Cdc42 is indirect, since overexpression of the Rac GEF TIAM did not result in Cdc42 activation the effects that we observe are indirect, i.e. through Rac1, or direct requires further molecular analysis. While FGD5, ITSN1 and TUBA have already been linked to Cdc42 activation [30] [31] [32] , our approach only detects moderate signaling towards Cdc42. However, it should be noted that our approach measures basal activity of the GEFs. The activity may be increased by signaling or affected by the binding of accessory/scaffolding proteins. A limitation of our assay is that we may miss the effects of endogenous accessory proteins due to over over-expression of the GEFs. Additionally, In ECs, we observe that ITSN1 and TUBA primarily localize at vesicles. But, it is unexplored whether Cdc42 can get activated at these localized structures.
GEF activities of the full-length proteins can be influenced by auto-inhibitory domains 33 , protein-protein interactions and by phosphorylation of specific residues 34 . Although FL GEF studies may appear physiologically the most relevant, the use of isolated GEF domains limits complexity. A selection of our catalytic constructs induces elevated Cdc42 activation, most clearly for the membrane-linked, DHPH constructs of ITSN1, ITSN2 and PLEKHG1 and to some extent for FGD1 and PLEKHG4. This not only demonstrates the functionality of the respective DHPH domains, but also proposes these GEFs as interesting candidates in recruitment-and/or optogenetic systems, to locally induce Cdc42 activation at the plasma membrane. We 35 , and others 36, 37 , have already demonstrated the value of these approaches in biological systems. Interestingly, we observe distinct trends in activation when comparing YFP/CFP ratio-and corresponding activity analyses. Compared to DHPH domains, FL GEFs exhibit higher activation potencies measured by 'relative activity' as compared to YFP/CFP ratio analysis. This implies that the power of catalytic GEF-mediated Cdc42 activation largely depends on the expression level of respective DHPH domains.
Previously, we observed with a similar strategy that the PH domain of p63RhoGEF has an autoinhibitory role and that the isolated DH domain has high activity towards RhoA 35 .
However, we did not find a similar role for the PH domain in any of the GEFs that we analyzed.
Strikingly, the isolated DH domains (with the exception of the DH domain of FGD1) did not show any activity in a cellular context. It appears that the PH domains of the Cdc42 GEFs that we selected have a stimulatory rather than inhibitory role.
In contrast to the previous-mentioned GEFs, effects of DHPH domains of FGD5, PLEKHG2 and pRex1 are either small or absent. For these GEFs, additional domains could be required for full activity; this will require additional domain-and activity analyses.
In conclusion, this study provides new insights regarding GEF-mediated Cdc42 activation in live, primary human ECs. Our FRET-based GEF screening method identifies FL PLEKHG2, FGD1, PLEKHG1 and pRex1 as prominent Cdc42 activators. Additionally, catalytic domains of ITSN1, ITSN2 and PLEKHG1 behave as potential activators for localinduced Cdc42 activation at the plasma membrane. Overall, these findings uncover novel potential Cdc42-related (signaling) studies in the endothelium.
Methods
Plasmids
FL GEFs
For Asef2 (kind gift from D. Webb) and pRex1 (kind gift from H.C. Welch), mTq2 and mCherry were amplified by PCR. PCR products (inserts) and vectors were cut with restriction enzymes. Next, digested products were ligated to generate mTq2-and mCherry GEF fusions.
For -Pix and TrioN (kind gifts from J. van Buul), vectors and GEF constructs were cut with restriction enzymes Next, digested products were ligated to generate mTq2-and mCherry GEF fusions. were amplified by PCR. PCR products (inserts) and vectors were cut with restriction enzymes.
Next, digested products were ligated to generate mTq2-and mCherry GEF fusions.
Corresponding PCR primers, restriction enzymes, and cloning products are listed in Table 1 .
DH(PH) truncation constructs
DH and DHPH domains of FGD1, FGD5, ITSN1, ITSN2, PLEKHG1, PLEKHG2, PLEKHG4 and pRex1 were amplified by PCR, using the same template constructs as for the cloning of the FL constructs. Next, PCR products (inserts) and vectors were cut with restriction enzymes.
Finally, inserts were ligated into vectors to generate for each GEF mCherry-DH, Lck-mCherry-DH, mCherry-DHPH and Lck-mCherry-DHPH constructs. An overview of PCR primers and restriction enzymes are listed in Table 2 .
Others
Cdc42-G14 (cDNA.org) was amplified by polymerase chain reaction (PCR), using forward primer (BsrGI site in uppercase): gcTGTACAagtccatgcagacaattaagtgtgt and reverse primer 3'-pcdna: gtcgaggctgatcagcgg. PCR product was digested with BsrGI and XbaI and inserted in a clontech style backbone. The Rac1 FRET sensor 25 and Cdc42 FRET sensor 26, 38 were as published in the cited references. 
Confocal imaging
Transfected HUVECs were grown to a monolayer, washed in PBS (1mM CaCl2 and 0.5 mM 
Data analysis
All image acquisitions were background corrected and YFP acquisitions were bleed-through corrected (55% leakage of the CFP into the YFP channel). FRET images in Figure 3 were obtained by ImageJ, according to refs 25, 39 .
YFP/CFP ratio analysis was performed in Matlab (Matlab, The MathWorks, Inc., Natick, Massachusetts, United States). The Matlab script was first described in ref 35 . TheilSen estimation analysis was performed according to Supplemental Figure S1 . Of note, median slopes were determined and shown in the graphs, since median values are less prone to outliers.
The graphs were made with PlotsOfData, showing the data as jittered dots, the median YFP/CFP values as a line and the median 'activity' values as a circle with 95% confidence interval indicated by a bar. The 95% confidence interval for the median was obtained by bootstrapping (1000 samples).
Data availability
The data generated during this study is available at Zenodo.org: 
